Effect of Roselle-based Drink on Blood Pressure and Skin

October 19, 2021 updated by: Chin Kun Wang, Chung Shan Medical University

Effect of Roselle-based Drink on Blood Pressure, Antioxidative Activity and Skin Condition

This randomized, placebo-controlled, double-blind, and cross-over study was designed to check whether the roselle-based drink (2 bottles every day) can alter blood pressure and skin condition in elderly healthy subjects.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The subjects were assigned into two groups (control group and test group), each group subject was requested to drink 2 bottles every day (100 mL/bottle, one in the morning and another in the evening), the rate of drinking is 75.42%. There are 39 subjects (25 females and 14 males) completely involved in the thirteen-month trial (cross-over). Blood samples were collected at the initial, 3rd, 6th, 7th, 10th, 13th months of the trial. Skin examinations were performed at the initial, 6th, 7th, 13th months.

Study Type

Interventional

Enrollment (Actual)

52

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Taichung
      • Taichung city, Taichung, Taiwan, 40201
        • Chung Shan Medical University

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

40 years to 81 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Healthy adults
  • Subjects should not be under any medication
  • Subject must be able to drink

Exclusion Criteria:

  • Subjects with chronic renal, liver or cardiac disorders, Diabetes, hyperlipidemia.
  • Also pregnant women, chain smokers, high alcohol consumers should not be included.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Prevention
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Triple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Placebo Comparator: Placebo/Control
Placebo drink-- Orally (200 ml/day)
Roselle and placebo drink for 6 months
Other Names:
  • Roselle Drink (SF-R product of Han Bu)
Experimental: Roselle Based drink (Test)
Roselle-Based Drink--- Orally (200 ml/day)
Roselle and placebo drink for 6 months
Other Names:
  • Roselle Drink (SF-R product of Han Bu)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Blood pressure by sphygmomanometer (mmHg)
Time Frame: 6 months
Both systolic and diastolic blood pressure were changed after Roselle drink
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Chin-Kun Wang, Ph.D, Chung Shan Medical University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 11, 2017

Primary Completion (Actual)

June 15, 2018

Study Completion (Actual)

October 19, 2018

Study Registration Dates

First Submitted

September 29, 2021

First Submitted That Met QC Criteria

October 18, 2021

First Posted (Actual)

October 19, 2021

Study Record Updates

Last Update Posted (Actual)

October 26, 2021

Last Update Submitted That Met QC Criteria

October 19, 2021

Last Verified

October 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • CS11102

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Other Skin and Subcutaneous Infections

Clinical Trials on Drink

3
Subscribe